HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in HTG Molecular Diagnostics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
–
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$39.7K
2
-$14K
3
-$4K
4
BlackRock
BlackRock
New York
-$3.48K
5
Morgan Stanley
Morgan Stanley
New York
-$2.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
–
UBS Group
2
UBS Group
Switzerland
–
TRCT
3
Tower Research Capital (TRC)
New York
–
BlackRock
4
BlackRock
New York
–
Morgan Stanley
5
Morgan Stanley
New York
–
HWM
6
HighMark Wealth Management
Minnesota
–
NA
7
Nordwand Advisors
Pennsylvania
–
AF
8
Allworth Financial
California
–
Wells Fargo
9
Wells Fargo
California
–
TWA
10
TCI Wealth Advisors
Arizona
–